Catalyst Wire Dossier Catalyst Wire Dossier

Tazbentetol

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tazbentetol, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Tazbentetol in ALS Participants [Phase 2, Phase 3]

See pricing